Publication of Supplement

Southern Housing
18 September 2024
 


 

Publication of Supplement to Programme Admission Particulars

 

Following our recent upgrade to G1 by the Regulator of Social Housing and confirmation of our credit ratings, Moody's A3 stable and Fitch A negative, we have today published a supplement to our EMTN programme.  

The following supplement to the programme admission particulars (the Supplement) has been approved by the London Stock Exchange and is available for viewing:

Supplement dated 18 September 2024 to the Programme Admission Particulars dated 18 June 2024 relating to the £1,000,000,000 Note Programme of Southern Housing.

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/7537E_1-2024-9-18.pdf

 

 

 

MORE INFORMATION

Investors@SouthernHousing.org.uk

DISCLAIMER ‑ INTENDED ADDRESSEES

Please note that the information contained in the Supplement and the Programme Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Programme Admission Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Programme Admission Particulars is not addressed.  Prior to relying on the information contained in the Supplement or Programme Admission Particulars you must ascertain from the Programme Admission Particulars whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

Southern Housing is a community benefit society with registered number 8983 and registered as a Registered Provider with the Regulator of Social Housing with number 5171.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100